Almost a century ago, the discovery of antibiotics like penicillin revolutionized medicine by harnessing the natural bacteria-killing abilities of microbes. Today, a new study by researchers suggest that natural-product antibiotic discovery is about to accelerate into a new era, powered by artificial intelligence (AI).
The study, published in Cell, details how the researchers used a form of AI called machine learning to search for antibiotics in a vast dataset containing the recorded genomes of tens of thousands of bacteria and other primitive organisms. This unprecedented effort yielded nearly one million potential antibiotic compounds, with dozens showing promising activity in initial tests against disease-causing bacteria.
“AI in antibiotic discovery is now a reality and has significantly accelerated our ability to discover new candidate drugs. What once took years can now be achieved in hours using computers” said study co-senior author.
Nature has always been a good place to look for new medicines, especially antibiotics. Bacteria, ubiquitous on our planet, have evolved numerous antibacterial defenses, often in the form of short proteins (“peptides”) that can disrupt bacterial cell membranes and other critical structures. While the discovery of penicillin and other natural-product-derived antibiotics revolutionized medicine, the growing threat of antibiotic resistance has underscored the urgent need for new antimicrobial compounds.
In recent years, the researchers have pioneered AI-powered searches for antimicrobials. They have identified preclinical candidates in the genomes of contemporary humans, extinct Neanderthals and Denisovans, woolly mammoths, and hundreds of other organisms. One of the lab’s primary goals is to mine the world’s biological information for useful molecules, including antibiotics.
For this new study, the research team used a machine learning platform to sift through multiple public databases containing microbial genomic data. The analysis covered 87,920 genomes from specific microbes as well as 63,410 mixes of microbial genomes—“metagenomes”—from environmental samples. This comprehensive exploration spanned diverse habitats around the planet.
This extensive exploration succeeded in identifying 863,498 candidate antimicrobial peptides, more than 90 percent of which had never been described before. To validate these findings, the researchers synthesized 100 of these peptides and tested them against 11 disease-causing bacterial strains, including antibiotic-resistant strains of E. coli and Staphylococcus aureus.
“Our initial screening revealed that 63 of these 100 candidates completely eradicated the growth of at least one of the pathogens tested, and often multiple strains,” the author said. “In some cases, these molecules were effective against bacteria at very low doses.”
Promising results were also observed in preclinical animal models, where some of the potent compounds successfully stopped infections. Further analysis suggested that many of these candidate molecules destroy bacteria by disrupting their outer protective membranes, effectively popping them like balloons.
The identified compounds originated from microbes living in a wide variety of habitats, including human saliva, pig guts, soil and plants, corals, and many other terrestrial and marine organisms. This validates the researchers’ broad approach to exploring the world’s biological data.
Overall, the findings demonstrate the power of AI in discovering new antibiotics, providing multiple new leads for antibiotic developers, and signaling the start of a promising new era in antibiotic discovery.
Latest News
Regular snoring could be ba…
By newseditor
Posted 24 Jun
Circadian rhythm drives the…
By newseditor
Posted 21 Jun
Six distinct types of depre…
By newseditor
Posted 21 Jun
Key role of a growth factor…
By newseditor
Posted 21 Jun
Bidirectional BCI functiona…
By newseditor
Posted 19 Jun
Other Top Stories
A toxic substance found in Staph bacteria stimulates tissue regener…
Read more
Will SARS-CoV-2 become endemic?
Read more
Evaluation of three coronavirus interactions with host targets
Read more
Fats provide immunity against bacteria
Read more
New blood test predicts which COVID-19 patients will develop severe…
Read more
Protocols
Deciphering spatial domains…
By newseditor
Posted 23 Jun
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
A co-culture system of macr…
By newseditor
Posted 10 Jun
Publications
Social Isolation and Loneli…
By newseditor
Posted 24 Jun
Regular snoring is associat…
By newseditor
Posted 24 Jun
Programmed cell death: NINJ…
By newseditor
Posted 22 Jun
Circadian-clock-controlled…
By newseditor
Posted 21 Jun
Personalized brain circuit…
By newseditor
Posted 21 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar